Loxo Oncology, Inc.

CIK 1581720 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Loxo Oncology, Inc..

Recent SEC filings

FiledFormAccession number
Feb 14, 2020SC 13G/A0001140361-20-003307
Jan 8, 2020SC 13G/A0000902219-20-000048
Feb 25, 201915-12B0001193125-19-049296
Feb 21, 2019EFFECT9999999995-19-000306
Feb 15, 2019SC 13D/A0001193125-19-041750
Feb 15, 20198-K0001193125-19-042505
Feb 15, 2019S-8 POS0001193125-19-042509
Feb 15, 2019S-8 POS0001193125-19-042527
Feb 15, 2019S-8 POS0001193125-19-042532
Feb 15, 201940001567619-19-004575
Feb 15, 2019SC 13D/A0000950142-19-000290
Feb 15, 2019SC 14D9/A0001193125-19-041759
Feb 15, 2019S-8 POS0001193125-19-042539
Feb 15, 201940001567619-19-004572
Feb 15, 201940001567619-19-004573
Feb 15, 201940001567619-19-004569
Feb 15, 201940001567619-19-004576
Feb 15, 201940001567619-19-004566
Feb 15, 201940001567619-19-004574
Feb 15, 201940001567619-19-004568
Feb 15, 2019POS AM0001193125-19-042490
Feb 15, 2019POSASR0001193125-19-042498
Feb 15, 201940001567619-19-004571
Feb 15, 201940001567619-19-004567
Feb 15, 201940001567619-19-004570